Australian investors seeking diversification beyond the ASX are turning to New Zealand's NZX market in 2026, drawn by attractive valuations, high dividend yields in select names, exposure to renewable energy and healthcare, and the benefits of a closely aligned economy and currency. With the NZX 50 showing signs of recovery after a subdued 2025, brokers and analysts have highlighted quality companies poised for growth as New Zealand's economy rebounds from slower growth and interest rate pressures.

While no investment is guaranteed and currency fluctuations between the Australian and New Zealand dollars can affect returns, many NZ stocks offer defensive qualities or growth potential that complement Australian portfolios. Here are 10 New Zealand-listed stocks frequently cited by analysts for 2026, based on recent broker picks, sector tailwinds and fundamental strength as of late March 2026.

Mercury NZ Logo
Mercury NZ Logo
  1. Mercury NZ (MCY.NZ) — Often ranked among the top performers in the NZX 50, this gentailer (generator-retailer) stands out for its renewable-heavy generation portfolio and pipeline of projects supporting New Zealand's electrification push. Brokers like Craigs Investment Partners favor it for above-average dividend growth potential and defensive earnings in a recovering economy. As households and industries shift toward more electric vehicles and heating, Mercury's hydro and wind assets position it well.
  2. Summerset Group (SUM.NZ) — A leading retirement village operator, Summerset has been a consistent broker favorite for 2026 due to New Zealand's ageing population and recent sector recovery. Shares rose strongly in late 2025, and analysts see further upside from occupancy gains and development pipelines. Its model of integrated care and sales of occupation rights provides resilient cash flows, making it appealing for income-focused Australian investors.
  3. Freightways (FRW.NZ) — This logistics and express parcels company offers cyclical exposure to New Zealand's economic rebound. With strong brands and dense networks, Freightways is expected to benefit from rising consumer spending and e-commerce volumes. Multiple brokers, including those in the New Zealand Herald's annual picks, highlighted it as a quality compounder trading at attractive valuations after earlier pressures.
  4. EBOS Group (EBO.NZ) — The diversified healthcare, medical supplies and animal care distributor has faced share price weakness in 2025 but is widely tipped for a recovery in 2026. Its operations span Australia and New Zealand, providing natural cross-border appeal for Aussie investors. Analysts point to stable demand in pharmaceuticals and pet care, plus potential margin improvements as supply chain issues ease.
  5. Fisher & Paykel Healthcare (FPH.NZ) — A global leader in respiratory care and medical devices, FPH remains a high-quality growth name despite its premium valuation. Recent NZX 50 performance data shows solid gains in early 2026, driven by innovation in hospital and home healthcare products. For Australians, it offers exposure to premium healthcare trends with strong export earnings that can benefit from a weaker NZ dollar.
  6. Meridian Energy (MEL.NZ) — Another major renewable energy player, Meridian complements Mercury with its hydro and wind focus. It frequently appears in market updates as a top gainer, supported by New Zealand's push toward 100% renewable electricity. Brokers see steady dividends and growth from data center demand and industrial electrification.
  7. Auckland International Airport (AIA.NZ) — As New Zealand's largest gateway, AIA stands to gain from recovering international tourism and domestic travel. Capital expenditure programs aimed at capacity expansion position it for long-term passenger growth. Australian investors may appreciate its similarity to familiar infrastructure assets while benefiting from trans-Tasman travel ties.
  8. Infratil (IFT.NZ) — This infrastructure investor holds stakes in renewable energy, data centers and transport assets, offering diversified exposure to growth themes. It has shown resilience and appears in recent performance leaders, with analysts noting its role in New Zealand's infrastructure upgrade cycle.
  9. Contact Energy (CEN.NZ) — A gentailer with a balanced generation mix, Contact has been active with equity raisings to fund growth. It provides another angle on the energy transition and is often mentioned alongside peers for reliable dividends in a normalizing interest rate environment.
  10. Ryman Healthcare (RYM.NZ) — Another retirement sector name, Ryman is viewed by some brokers as a leveraged recovery play amid demographic tailwinds. While it carries higher risk than Summerset due to development exposure, analysts see potential upside if occupancy and sales improve as expected in 2026.

The NZX 50 has traded around 12,700–13,000 points in March 2026, showing volatility tied to global events such as the US-Iran conflict and domestic economic data. Broader themes supporting these picks include New Zealand's interest rate easing cycle, which benefits rate-sensitive sectors, and structural drivers like ageing demographics, renewable energy investment and healthcare demand.

Analysts caution that 2026 carries risks, including slower-than-expected global growth, persistent inflation or geopolitical shocks affecting commodity prices. Diversification remains essential, and these suggestions are not personalized advice. Investors should conduct their own research, review company reports and consider consulting a financial adviser familiar with cross-border investing.

Recent broker compilations, such as those from Craigs Investment Partners and the New Zealand Herald's annual survey, consistently emphasize quality businesses with strong balance sheets and clear growth paths. Retirement villages, logistics, healthcare distribution and renewables dominate the conversation as New Zealand emerges from a period of subdued activity.

Australian investors have historically found value in the "kiwi" market during periods when the NZX lagged the ASX, often due to differing economic cycles. With many NZ blue chips trading at reasonable multiples compared to some stretched ASX names, 2026 could offer selective opportunities.

In addition to individual stocks, Australians can gain broader NZ exposure through ETFs or managed funds, but direct holdings allow targeted bets on themes like electrification or demographics. As always, past performance is no guarantee of future results, and volatility can be higher in smaller markets.

Looking ahead, New Zealand's economy is forecast to improve modestly in 2026, supported by lower interest rates and tourism recovery. Companies with defensive earnings or exposure to these trends may reward patient investors.

For those considering the trans-Tasman leap, the 10 names above represent a cross-section of frequently recommended opportunities. Whether seeking income from utilities and retirement operators or growth from healthcare and infrastructure, New Zealand's market offers distinct characteristics that can complement an Australian-focused portfolio in 2026.